• Search
  • Advanced Search
Korean J Hepatol > Volume 12(3); 2006 > Article
1
The Korean Journal of Hepatology 2006;12(3): 315-317.
PIVKA-II as a Serological Marker of Hepatocellular Carcinoma
Sook-Hyang Jeong
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
KeyWords: Hepatocellular carcinoma; Tumor marker; PIVKA-II (Protein induced by vitamin K absence or antagonist-II); Des-gamma-carboxy prothrombin (DCP); alpha-Fetoprotein
TOOLS
METRICS Graph View
  • 2,488 View
  • 23 Download
Related articles

Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma2023 October;29(4)

Recent advances in the management of hepatocellular carcinoma2024 January;30(1)

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma2021 October;27(4)

Metabolic disease as a risk of hepatocellular carcinoma2021 January;27(1)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma2020 October;26(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 638
TOTAL : 1789381
Close layer